Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shea butter + ceramide is a topical combination product formulated primarily as a skin moisturizer and barrier repair agent. The formulation typically contains Butyrospermum parkii (shea butter), which acts as an emollient to soften and soothe dry or compromised skin, and Ceramide NP, a lipid molecule that helps restore the skin’s natural barrier function by replenishing essential lipids. This combination is used in over-the-counter creams for conditions such as eczema, atopic dermatitis, dry skin, and other forms of dermatitis. The mechanism of action involves both occlusive moisturizing from shea butter and reinforcement of the stratum corneum lipid matrix by ceramides to reduce transepidermal water loss and improve overall skin hydration[1][2][4][6]. These products are not FDA-approved drugs but are widely marketed for dermatological use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shea butter + ceramide.